Clinical Core Outcomes Sets in Real World Data
نویسندگان
چکیده
منابع مشابه
Modeling Real-World Data Sets
Traditionally, the performance of algorithms is evaluated using worst-case analysis. For a number of problems, this type of analysis gives overly pessimistic results: Worst-case inputs are rather artificial and do not occur in practical applications. In this lecture we review some alternative analysis approaches leading to more realistic and robust performance evaluations. Specifically, we focu...
متن کاملComparing ICP Variants on Real-World Data Sets
Many modern sensors used for mapping produce 3D point clouds, which are typically registered together using the iterative closest point (icp) algorithm. Because icp has many variants whose performances depend on the environment and the sensor, hundreds of variations have been published. However, no comparison frameworks are available, leading to an arduous selection of an appropriate variant fo...
متن کاملReal-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients
Venous thromboembolism (VTE) is a potential cause of morbidity and mortality in patients after major orthopaedic surgery. Based on the results of the international phase III RECORD (Regulation of Coagulation in Orthopaedic Surgery to Prevent Deep Vein Thrombosis and Pulmonary Embolism) program, the oral, direct Factor Xa inhibitor rivaroxaban has been approved in many countries for the preventi...
متن کاملDrugs: Real World Outcomes
It is our great pleasure to welcome you to Drugs: Real World Outcomes, the latest offering from Adis that targets research involving the use of real-world data. We all know that the gold standard in research is the randomized controlled clinical trial; however, we all also know that these trials by the nature of their design fail to inform clinicians on many fronts. While they provide vital con...
متن کاملImproving Realism in Clinical Trial Simulations via Real‐World Data
Simulation validity depends on how well sampling distributions used reflect real-patient characteristics, such as drug adherence, disease progression, and pharmacologic handling in the body. We challenge the current use of growth charts from nondisease-specific pediatrics in simulations for drug development. Complementary use of data from clinical trials and the real-world is expected to achiev...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2018
ISSN: 1098-3015
DOI: 10.1016/j.jval.2018.04.761